Nine hospitals offer pioneering knee repair therapy (2021/12/03)
其它新聞 Other News   
  • President Tsai makes list of ‘25 most influential women’
  • Intel chief says Taiwan ‘not a stable place’
  • Medigen wins international grant to conduct mixed-dose booster trial
  • Chang Gung Memorial Hospital begins trial of mixed-dose boosters
  • AIT honors Taiwanese participants of AMVER ocean rescue alliance
  • Pingtung celebrates Czech culture in 5-day festival
  • Taiwan premiere for award-winning documentary ‘Searching for Taromak’
  • Virtual reality system trains users in fire safety skills
  • Tai Tzu-ying named BWF Female Player of the Year, Lee-Wang pair nabs ‘Most Improved’
  • 英文 English 
    Nine hospitals offer pioneering knee repair therapy (2021/12/03)

    A new law has opened the door for cutting edge treatments for knee pain in Taiwan. The pioneering implant therapy known as ACI is now available, and could revolutionize care for people with joint problems. ACI involves grafting some of the patient's own cartilage cells into the damaged knee, to help it regenerate. The treatment can allow patients to return to normal activity with zero knee pain.

    Mr. Chen’s life was brought to a standstill when his knees began to degenerate. He even got an artificial knee replacement. But after successful ACI therapy, now he can walk as well as ever.

    Chen Hsin-cheng
    Knee replacement patient
    From time to time I walk all the way from our house on the first floor up to the 14th floor. I don’t want to take a walking stick or use a wheelchair. I’m autonomous. Today I feel the procedure was really worth it.

    Our knee joints are silent heroes, working seamlessly on every step we take. But for many, repetitive strain or a lack of care can damage our knees. In the past, the only solution was to get an artificial knee replacement, which can be tough to recover from. In recent years, ACI has become an alternative.

    ACI has been approved by the new Special Medical Treatment Law, and many of Taiwan’s big hospitals have got licenses to offer the therapy. So far, 45 patients have had ACI and experienced the regrowth of their knee cartilage. Early research suggests ACI can reduce knee pain, with little risk of adverse reactions.

    Dr. Hsiao Chin-fu
    Institute of Population Health Sciences
    A truly appropriate study would involve all the participants, all the patients, using the drug. That way, if we collect the data in a routine manner, it won’t be as confined as traditional clinical trials were in the past. The efficacy of the drug will be extended to a wider demographic.

    The Institute of Population Health Sciences has signed a contract with a biotech company to further analyze data from nine hospitals, which they hope will expedite clinical trials.

    Shih Chung-liang
    Deputy Minister of Health and Welfare
    You have a guarantee, whether in the research, in the product manufacturing, or among patients. We’ll do everything to push this forward on every level, so that Taiwan can truly become the biotech island of Asia.

    The Ministry of Health and Welfare places high hopes in the research. For an aging society, caring for degenerative diseases must be a priority. An exponential number of people will develop joint problems in the coming years, and hospitals want to get ready.
    中文 Chinese  



    [[患者 陳信呈]]





    [[衛福部次長 石崇良]]

    關於民視 常見問題 如何收看民視 意見信箱

    © 2009 FTV All Rights Reserved 版權所有‧盜用必究 Designed by FTV
    地址:244 新北市林口區信義路99號   觀服電話:(02)8601-8601 服務時間:週一至週日09:00-21:00   傳真:(02)8601-3955

    本網站使用 cookie 與其他技術為您提供更好的使用體驗, 請閱讀我們的的隱私權政策,通過使用我們的網站,表示您確認並同意我們的政策。